FLCN Gene Pneumothorax primary spontaneous Genetic Test
Welcome to DNA Labs UAE, where we offer the FLCN Gene Pneumothorax primary spontaneous Genetic Test. This test is designed to analyze the FLCN gene and detect mutations associated with Birt-Hogg-Dub syndrome (BHDS).
Test Components
- FLCN Gene Pneumothorax primary spontaneous Genetic Test
Price
The cost of the test is 4400.0 AED.
Sample Condition
We accept blood, extracted DNA, or one drop of blood on an FTA card as sample conditions.
Report Delivery
You can expect to receive your test report within 3 to 4 weeks.
Method
We utilize NGS (Next-Generation Sequencing) technology for this genetic test.
Test Type
The FLCN Gene Pneumothorax primary spontaneous Genetic Test falls under the category of Ear Nose Throat Disorders.
Doctor
This test is typically recommended by ENT Doctors.
Test Department
Our Genetics department handles this particular test.
Pre Test Information
Prior to undergoing the IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test, it is important to provide the clinical history of the patient. Additionally, a genetic counseling session may be conducted to draw a pedigree chart of family members affected by the IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS16.
Test Details
The FLCN gene is responsible for producing a protein called folliculin. Mutations in the FLCN gene are associated with Birt-Hogg-Dub syndrome (BHDS), a rare genetic disorder. BHDS is characterized by the development of multiple noncancerous tumors in the skin, lungs, and kidneys. One common manifestation of BHDS is primary spontaneous pneumothorax (PSP), which is the sudden collapse of a lung without any apparent cause. PSP can occur in individuals with BHDS due to lung cysts or blebs resulting from the FLCN gene mutation.
Our NGS genetic testing is a powerful tool that can analyze multiple genes simultaneously. It is particularly useful in identifying genetic mutations associated with various genetic disorders, including BHDS. By detecting mutations in the FLCN gene, NGS can provide valuable information for diagnosing BHDS and assessing the risk of developing associated complications such as PSP.
If an individual has a family history of BHDS or presents with symptoms suggestive of the condition, NGS genetic testing can be performed to identify mutations in the FLCN gene. This information can guide medical management, screening for associated tumors, and provide genetic counseling to affected individuals and their families.
| Test Name | FLCN Gene Pneumothorax primary spontaneous Genetic Test |
|---|---|
| Components | |
| Price | 4400.0 AED |
| Sample Condition | Blood or Extracted DNA or One drop Blood on FTA Card |
| Report Delivery | 3 to 4 Weeks |
| Method | NGS Technology |
| Test type | Ear Nose Throat Disorders |
| Doctor | ENT Doctor |
| Test Department: | Genetics |
| Pre Test Information | Clinical History of Patient who is going for IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test. A Genetic Counselling session to draw a pedigree chart of family members affected with IARS2 Gene Cataracts, growth hormone deficiency, sensory neuropathy, sensorineural hearing loss, and skeletal dysplasia NGS Genetic DNA Test gene IARS16 |
| Test Details |
The FLCN gene is responsible for producing a protein called folliculin. Mutations in the FLCN gene are associated with a rare genetic disorder called Birt-Hogg-Dub syndrome (BHDS). BHDS is characterized by the development of multiple noncancerous tumors in the skin, lungs, and kidneys. One of the common manifestations of BHDS is primary spontaneous pneumothorax (PSP), which is the sudden collapse of a lung without any apparent cause. PSP can occur in individuals with BHDS as a result of lung cysts or blebs that develop due to the FLCN gene mutation. Next-generation sequencing (NGS) genetic testing is a type of genetic test that can analyze multiple genes simultaneously. It is a powerful tool for identifying genetic mutations associated with various genetic disorders, including BHDS. NGS can detect mutations in the FLCN gene and provide valuable information for diagnosing BHDS and assessing the risk of developing associated complications such as PSP. If an individual has a family history of BHDS or presents with symptoms suggestive of the condition, NGS genetic testing can be performed to identify mutations in the FLCN gene. This information can help guide medical management, screening for associated tumors, and provide genetic counseling to affected individuals and their families. |
